Eli Lilly stops development of lupus drug; XTL shares soar

(Reuters) - Eli Lilly and Co said it would stop the development of its drug to treat the autoimmune disorder lupus, after it was found to be not effective enough in late-stage trials.

via Reuters: Health News Read More Here..